Clinical trial
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular…
NCT00379899 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00379899 |
|---|---|
| Title | ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis |
| Official title | A Randomized Study to Evaluate the Effects of Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease (CKD) Receiving Hemodialysis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease, End Stage Renal Disease, Coronary Artery Calcification, Vascular Calcification, Calcification, Cardiovascular Disease, Chronic Renal Failure, Hyperparathyroidism, Kidney Disease, Nephrology and 1 more |
| Intervention type | Drug |
| Interventions | cinacalcet |
| Enrollment | 360 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Sep 25, 2006 |
| Last update posted | Jul 23, 2014 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: